Literature DB >> 17440045

Regulation of hepatic Insig-2 by the farnesoid X receptor.

Melissa L Hubbert1, Yanqiao Zhang, Florence Y Lee, Peter A Edwards.   

Abstract

Activation of the farnesoid X receptor (FXRalpha) affects genes controlling many pathways, including those involved in bile acid and glucose homeostasis. Here we report that a critical gene involved in cholesterol homeostasis, Insig-2, was induced when mice or cultured cells were treated with FXRalpha agonists or infected with constitutively active FXRalpha. No such induction was observed in agonist-treated FXRalpha-/- mice. Further analysis, which included EMSAs, reporter gene activation, and chromatin immunoprecipitation, identified two functional FXRalpha response elements within intron 2 of the mouse Insig-2 gene. In addition to increasing hepatic Insig-2 protein levels in wild-type mice, FXRalpha activation also reduced lanosterol 14alpha-demethylase mRNA levels and 3-hydroxy-3-methylglutaryl-coenzyme A reductase protein levels. Together, these changes likely account for the decrease in cholesterol synthesis observed after activation of FXR in primary hepatocytes. In conclusion, the current study links hepatic FXRalpha activation to regulation of genes involved in cholesterol synthesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440045     DOI: 10.1210/me.2007-0089

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  17 in total

1.  Nutrigenomic analysis of the protective effects of bilberry anthocyanin-rich extract in apo E-deficient mice.

Authors:  Aurelie Mauray; Catherine Felgines; Christine Morand; Andrzej Mazur; Augustin Scalbert; Dragan Milenkovic
Journal:  Genes Nutr       Date:  2010-03-01       Impact factor: 5.523

2.  Differential regulation of bile acid and cholesterol metabolism by the farnesoid X receptor in Ldlr -/- mice versus hamsters.

Authors:  Christophe Gardès; Evelyne Chaput; Andreas Staempfli; Denise Blum; Hans Richter; G Martin Benson
Journal:  J Lipid Res       Date:  2013-02-21       Impact factor: 5.922

3.  Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia.

Authors:  Yanqiao Zhang; Liya Yin; Jody Anderson; Huiyan Ma; Frank J Gonzalez; Timothy M Willson; Peter A Edwards
Journal:  J Biol Chem       Date:  2009-12-07       Impact factor: 5.157

4.  The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2.

Authors:  Elizabeth J Tarling; Hannah Ahn; Thomas Q de Aguiar Vallim
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-01-15       Impact factor: 8.311

5.  Functional characterization of the semisynthetic bile acid derivative INT-767, a dual farnesoid X receptor and TGR5 agonist.

Authors:  Giovanni Rizzo; Daniela Passeri; Francesca De Franco; Gianmario Ciaccioli; Loredana Donadio; Giorgia Rizzo; Stefano Orlandi; Bahman Sadeghpour; Xiaoxin X Wang; Tao Jiang; Moshe Levi; Mark Pruzanski; Luciano Adorini
Journal:  Mol Pharmacol       Date:  2010-07-14       Impact factor: 4.436

6.  FXR activation by obeticholic acid or nonsteroidal agonists induces a human-like lipoprotein cholesterol change in mice with humanized chimeric liver.

Authors:  Romeo Papazyan; Xueqing Liu; Jingwen Liu; Bin Dong; Emily M Plummer; Ronald D Lewis; Jonathan D Roth; Mark A Young
Journal:  J Lipid Res       Date:  2018-03-20       Impact factor: 5.922

7.  Regulation of lipid metabolism by obeticholic acid in hyperlipidemic hamsters.

Authors:  Bin Dong; Mark Young; Xueqing Liu; Amar Bahadur Singh; Jingwen Liu
Journal:  J Lipid Res       Date:  2016-12-09       Impact factor: 5.922

8.  Bile acid-induced elevated oxidative stress in the absence of farnesoid X receptor.

Authors:  Masahiro Nomoto; Masaaki Miyata; Shanai Yin; Yasushi Kurata; Miki Shimada; Kouichi Yoshinari; Frank J Gonzalez; Kokichi Suzuki; Shigeki Shibasaki; Tohru Kurosawa; Yasushi Yamazoe
Journal:  Biol Pharm Bull       Date:  2009-02       Impact factor: 2.233

9.  Genome-wide interrogation of hepatic FXR reveals an asymmetric IR-1 motif and synergy with LRH-1.

Authors:  Hansook Kim Chong; Aniello M Infante; Young-Kyo Seo; Tae-Il Jeon; Yanqiao Zhang; Peter A Edwards; Xiaohui Xie; Timothy F Osborne
Journal:  Nucleic Acids Res       Date:  2010-05-18       Impact factor: 16.971

10.  REV-ERBalpha participates in circadian SREBP signaling and bile acid homeostasis.

Authors:  Gwendal Le Martelot; Thierry Claudel; David Gatfield; Olivier Schaad; Benoît Kornmann; Giuseppe Lo Sasso; Antonio Moschetta; Ueli Schibler
Journal:  PLoS Biol       Date:  2009-09-01       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.